Log in to save to my catalogue

The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+...

The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ddf8dfb50aae49a7b024afb7204f8906

The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses

About this item

Full title

The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2019-11, Vol.11 (11), p.612

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Explosive growth in nanotechnology has merged with vaccine development in the battle against diseases caused by bacterial or viral infections and malignant tumors. Due to physicochemical characteristics including size, viscosity, density and electrostatic properties, nanomaterials have been applied to various vaccination strategies. Nanovaccines, a...

Alternative Titles

Full title

The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ddf8dfb50aae49a7b024afb7204f8906

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ddf8dfb50aae49a7b024afb7204f8906

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics11110612

How to access this item